Biovail Income Statement
View: Annual | Quarterly
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 842.8 | 1,067.7 | 935.5 |
| Cost of Goods Sold | 223.7 | 211.1 | 206.5 |
| Gross Profit | 619.1 | 856.6 | 729.0 |
| Gross Profit Margin | 73.5% | 80.2% | 77.9% |
| SG&A Expense | 330.4 | 522.0 | 319.4 |
| Depreciation & Amortization | 100.8 | 95.7 | 107.7 |
| Operating Income | 188.0 | 238.9 | 301.9 |
| Operating Margin | 22.3% | 22.4% | 32.3% |
| Nonoperating Income | 30.5 | 26.8 | 4.6 |
| Nonoperating Expenses | 9.7 | 35.2 | 37.1 |
| Income Before Taxes | 208.7 | 230.0 | 269.4 |
| Income Taxes | 13.2 | 14.5 | 22.5 |
| Net Income After Taxes | 195.5 | 215.5 | 246.8 |
| Continuing Operations | 195.5 | 215.5 | 246.8 |
| Discontinued Operations | -- | (3.8) | (10.6) |
| Total Operations | 195.5 | 211.6 | 236.2 |
| Total Net Income | 195.5 | 211.6 | 236.2 |
| Net Profit Margin | 23.2% | 19.8% | 25.2% |
| Diluted EPS from Total Net Income ($) | 1.22 | 1.32 | 1.48 |
| Dividends per Share | 2.00 | 0.50 | 0.50 |





